Journal Information

Statistics

Follow this link to access the full text of the article

Case Report
Chronic recalcitrant erythema nodosum leprosum: therapeutic dilemma and role of mycobacterium indicus pranii vaccine
Sunil Kumar Gupta
Corresponding author
dr.sunil_30@yahoo.co.in

Corresponding author.
, Sushantika Kumari
Department of Dermatology, All India Institute of Medical Sciences, Gorakhpur, India
Read
8183
Times
was read the article
2654
Total PDF
5529
Total HTML
Share statistics
Article information
ISSN: 03650596
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 6 71 19 90
2025 5 302 79 381
2025 4 225 56 281
2025 3 240 43 283
2025 2 250 76 326
2025 1 182 54 236
2024 12 177 60 237
2024 11 200 59 259
2024 10 166 68 234
2024 9 210 80 290
2024 8 225 121 346
2024 7 208 107 315
2024 6 211 78 289
2024 5 198 57 255
2024 4 200 77 277
2024 3 203 84 287
2024 2 177 73 250
2024 1 135 47 182
2023 12 119 62 181
2023 11 110 82 192
2023 10 81 74 155
2023 9 94 76 170
2023 8 65 33 98
2023 7 94 34 128
2023 6 73 61 134
2023 5 73 41 114
2023 4 59 17 76
2023 3 72 54 126
2023 2 69 25 94
2023 1 66 58 124
2022 12 76 38 114
2022 11 92 59 151
2022 10 102 65 167
2022 9 64 63 127
2022 8 58 52 110
2022 7 57 63 120
2022 6 53 66 119
2022 5 60 52 112
2022 4 78 57 135
2022 3 64 79 143
2022 2 109 45 154
2022 1 106 92 198
2021 12 52 68 120
2021 11 3 0 3
Show all

Follow this link to access the full text of the article

Idiomas
Anais Brasileiros de Dermatologia
en pt
Cookies policy Política de cookies
To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.